Dr. M. Umakanth
Abstract: Background, Anaemia is one of the common complications associated with Chronic Kidney Disease (CKD) liable for the increase in the morbidity and mortality in such patients. Numerous factors have been attributed to cause renal anemia, amongst which hyperparathyroidism is one of the less recognized reasons. The excess amount of Parathyroid Hormone (PTH) secondary to CKD has been suggested to be a contributing factor for anaemia. The introduction of erythropoietin considerably improved anaemia in patients with CKD by relieving symptoms and avoiding complications associated with blood transfusion. The aim of the study is to see the prevalence of the anemia severity among CKD patients who are on regular dialysis. A Methodology, Prospective, Observational study was conducted at the Teaching Hospital Batticaloa, SriLanka. Results, Majority of the dialysis patients 26 (62 %) had hemoglobin in the range of 7-9g/dl, 7 (16.7 %) patients had hemoglobin of more than 10g/dl and 4 (9.5 %) patients had hemoglobin below 7g/dl. This study is clearly shown that almost all (100 %) dialysis population had anemia. Conclusion, The use of iron therapies and erythropoiesis stimulating agents (ESAs) has allowed improvement in patients with anemia of CKD.
Keywords: Anemia among Chronic Kidney Disease and anemia among hemodialysis patient